Zuberitamab
Zuberitamab Basic information
- Product Name:
- Zuberitamab
- Synonyms:
-
- Zuberitamab
- Research Grade Zuberitamab (DHC90719)
- Research Grade Zuberitamab
- CAS:
- 2251143-19-6
- MW:
- 0
- Mol File:
- Mol File
More
Less
Zuberitamab Usage And Synthesis
Uses
Zuberitamab (HS006) is a monoclonal antibody that targets CD20 and can be used in cancer research, including diffuse large B-cell lymphoma[1].
in vivo
Zuberitamab (0.1?mg/kg, intravenous injection, on day 0 and 10, 2 weeks) alone has no or minimal effect on tumor growth, when combined with BR105 results in significant inhibition of tumor growth with good anti-tumor efficacy in IRPα-humanized B-NDG mice tumor xenograft model[1].
References
[1] Zhen-Hua Wu, et al. Preclinical characterization of the novel anti-SIRPα antibody BR105 that targets the myeloid immune checkpoint. J Immunother Cancer. 2022 Mar;10(3):e004054. DOI:10.1136/jitc-2021-004054
ZuberitamabSupplier
ShangHai Biochempartner Co.,Ltd
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com
Guangzhou Hongyuan Chemical Co.,Ltd
- Tel
- 15817493340
- 981810490@qq.com
Wuhan Chemstan Biotechnology Co., Ltd.
- Tel
- 027-65317797 15926423062
- 422450190@qq.com
Biolab Reagents
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com
Wanxin Biotechnology (Jiaxing) Co., LTD
- Tel
- 0573-83568680 18057391398
- 3956524501@qq.com